Public Policy Dynamics EU #9

by RPP colleagues

Health and Politics in the European Union

  • A new agreement on joint rules bringing increased transparency has been reached between the European Parliament, and the European Commission and Council, aiming at upgrading their transparency register.
  • On 19 April, the Special Committee on Beating Cancer (BECA) published a Synopsis Report, addressing the effect of the Covid-19 pandemic on cancer prevention, health services, cancer patients and research. Further, the European Commission has published a public consultation regarding the European Health Data Space (EHDS), as part of the European Health Union.
  • In response to increasing travelling leniency within EU countries, and the progress of national vaccination efforts, the European Commission has announced it is set to ease non-essential travel restrictions for fully vaccinated visitors, as well as for those coming from countries with an overall good health situation. Separately, the European Medicines Agency has initiated an evaluation on the extension of the use of the Comirnaty vaccine to people aged between 12 and 15. In addition, the European Commission has developed a strategy on Covid-19 therapeutics aiming at supporting the development and availability of much-need Covid-19 therapeutics.

 

Politics

  • In the course of April, the European Parliament approved an agreement on joint rules bringing increased transparency to the activities of interest groups at the EU level, with a deal struck with the Commission and Council. This agreement calls for the implementation of new actions by the relevant Parliament’s bodies.

 

Health

  • On 19 April, the Special Committee on Beating Cancer (BECA) published a Synopsis Report of the Public consultation held regarding the lessons leant from the Covid-19. This consultation highlighted, among other issues, behavioural changes as a result of the crisis, and its impact on cancer prevention, health services, cancer patients and research. Several recommendations and new prevention measures and treatments were raised and will be discussed on 10 May.

  • Separately, the European Commission has published a public consultation regarding the European Health Data Space (EHDS), as part of the European Health Union. The Commissioner for Health and Food Safety Stella Kyriakides argued that the EHDS will be an essential component of the European Health Union and will allow for EU-wide collaboration for better healthcare, better research and better health policy-making.

 

Covid-19

  • In response to the increasing leniency on travelling within EU countries and the progress of national vaccination efforts, the European Commission has announced its intention to ease the current non-essential travel restrictions for fully vaccinated visitors, as well as for those coming from countries with an overall good health situation, all while ensuring it can promptly react to cases of the emergence of new variants or outbreaks. However, the President of the European Commission emphasised that this proposal only concerns travellers who can prove they have received a dose from a European Medicines Agency (EMA)-approved vaccine. Nevertheless, this proposal still needs to be agreed on by EU Member States.

  • The EMA has started an evaluation on the extension of the use of the Comirnaty vaccine, currently allowed for to those aged 16 years old and above, to younger people aged between 12 and 15. The final decision is expected to be published in the course of June.

  • In-line with the successful vaccination strategies, the European Commission has developed a strategy on Covid-19 therapeutics. With the aim of supporting the development and availability of much-need Covid-19 therapeutics, this strategy includes specific actions and goals, including authorising three new therapeutics to treat Covid-19 by October 2021.

Cookie-Settings

At rpp-group.com we use cookies (e.g. tracking and analytical cookies), which enable us to analyse and measure user data. Further information can be found here: